🔍
Search Results - david+kim
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Treatment of fibrosis-associated pathologies through downstream TGF-β pathway inhibition
Value PropositionInhibits downstream signaling pathway of TGF-β signaling, reducing pleiotropic and off-target effects.Selectively targets tissue specific calpains, increasing efficacy as compared to current TGF-β signaling pathway inhibitory methods.Applicable to several disease models with specific focus on epithelial-to-mesenchymal transition pathologies....
Published: 3/13/2025
|
Inventor(s):
David Kim
,
Harry Dietz
Keywords(s):
Biomarker
,
Cancers
,
Clinical Diagnostics
,
Disease Indication
,
Fibrosis Disorders
,
In Vitro Diagnostics
,
Mechanism-of-action Biomarker
,
Therapeutic Matter
,
Therapeutics
Category(s):
Clinical and Disease Specializations
,
Clinical and Disease Specializations > Fibrosis
,
Clinical and Disease Specializations > Oncology
,
Technology Classifications > Diagnostics > Biomarkers
,
Technology Classifications > Therapeutic Modalities > Targets
,
Technology Classifications > Diagnostics > In Vitro Diagnostics
,
Technology Classifications > Diagnostics
,
Technology Classifications > Therapeutic Modalities
JHTV Home
|
Search
|
Login/Subscribe
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by
Inteum